Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $61.18.
Several analysts have recently issued reports on TEM shares. William Blair reissued a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Loop Capital dropped their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Wolfe Research lowered shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, TD Cowen restated a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th.
Get Our Latest Stock Report on TEM
Insider Activity
Institutional Trading of Tempus AI
Institutional investors and hedge funds have recently bought and sold shares of the stock. Wells Fargo & Company MN increased its stake in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after buying an additional 278 shares during the period. First Horizon Advisors Inc. acquired a new stake in Tempus AI during the 3rd quarter valued at approximately $30,000. Geode Capital Management LLC raised its holdings in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares during the last quarter. Operose Advisors LLC acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $25,000. Finally, Prestige Wealth Management Group LLC boosted its stake in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.
Tempus AI Stock Performance
Shares of NASDAQ:TEM opened at $47.17 on Friday. The business’s 50 day simple moving average is $55.33 and its 200 day simple moving average is $51.71. Tempus AI has a 1 year low of $22.89 and a 1 year high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- Most active stocks: Dollar volume vs share volume
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Ride Out The Recession With These Dividend Kings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Most Volatile Stocks, What Investors Need to Know
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.